Twain Therapeutics is a biotechnology company developing precision IL-2/15 therapies for cancer. The company was founded using core strategies development by Cheng I Wang and John E Connolly. Our current team consist of:
Scientific Co-Founder
Scientific Co-Founder
Chief Operations Officer
VP Business Development